3 Chronic Urticaria Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting Chronic Urticaria Studies in Birmingham

NCT06868212Recruiting

A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines

This is a US, multi-center, randomized, double-blind, double-dummy, Phase 3b study to evaluate efficacy of remibrutinib (25 mg twice daily \[b.i.d.\] by mouth \[p.o.\]) compared to dupilumab (600 mg l...

Birmingham, ALPHASE3400 participantsNovartis Pharmaceuticals

View Study Details

NCT07266402Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

The purpose of this Phase 3, randomized, double-blind, placebo-controlled study is to assess the activity and safety of barzolvolimab compared to placebo in participants with cold induced urticaria or...

Birmingham, ALPHASE3240 participantsCelldex Therapeutics

View Study Details

NCT06931405Recruiting

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

This is a 2-part, proof-of-concept study to be conducted globally, designed to evaluate the safety, tolerability, clinical activity, pharmacokinetics, and pharmacodynamics of BLU-808, a wild type KIT ...

Birmingham, ALPHASE2105 participantsBlueprint Medicines Corporation

View Study Details

About Chronic Urticaria Clinical Trials in Birmingham

Chronic urticaria involves recurring episodes of itchy, red welts (hives) lasting more than six weeks. Chronic spontaneous urticaria (CSU) occurs without an identifiable trigger. Treatment includes antihistamines and biologics like omalizumab.

There are currently 3 chronic urticaria clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 745 participants. Research is being sponsored by Novartis Pharmaceuticals, Celldex Therapeutics, Blueprint Medicines Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.

Chronic Urticaria Clinical Trials in Birmingham — FAQ

Are there chronic urticaria clinical trials in Birmingham?

Yes, there are 3 chronic urticaria clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What chronic urticaria treatments are being tested?

The 3 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for chronic urticaria.

Data updated July 17, 2026 from ClinicalTrials.gov